Anthropic operates a wet biology lab in the Bay Area, the company confirmed to TechCrunch. The lab runs physical experiments to ground-truth what its AI models produce. Head of life sciences Eric Kauderer-Abrams told Reuters: "The final test is still, and will be for a while, in real lab work."

The move follows Anthropic's April acquisition of stealth AI biotech Coefficient Bio. The lab works like a standard biotech facility, running some internal research while also engaging external partners. Focus is fundamental biology, not drug discovery. Anthropic explicitly avoided the drug discovery framing to protect its relationships with pharma customers and partners, a category representing major commercial revenue.

The dynamic to watch is simple: Anthropic's CEO Dario Amodei claimed last week that AI could cure most major diseases within five to ten years. A wet lab is how you test whether that claim moves from language to evidence. TechCrunch reports Anthropic declined to specify current projects. Watch whether pharma partners treat this lab as collaboration infrastructure or a future competitive threat.